share_log
Reuters ·  May 2 08:05
Protara Therapeutics Inc: Preliminary Data From Six-Month Evaluable Patients in Advanced-2 Trial of Tara-002 in Nmibc Expected in 2H 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment